fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Search » J B Chemicals & Pharmaceuticals Ltd

J B Chemicals Pharmaceuticals Ltd

Updated on October 15, 2020

Stock/Share Code - JBCHEPHARM

J B Chemicals & Pharmaceuticals is engaged in the business of manufacture and marketing of diverse range of pharmaceutical formulations, herbal remedies and APIs.(Source : 201903 Annual Report Page No: 104)

Below is the details of JBCHEPHARM J B Chemicals Pharmaceuticals Ltd

Market Cap₹5,953 Cr.
Current Price ₹1,022 as on 21 Oct 20
52 Week High / Low Price₹828.85 / ₹315.05
Face Value₹2
Stock P/E23.30
Book Value₹187.01
Dividend Yield1.43 %
ROCE21.81 %
ROE17.44 %
Sales Growth (3yrs)11.78 %
SectorPharmaceuticals
IndustryPharmaceuticals - Indian - Bulk Drugs & Formln
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company is virtually debt free.
Cons: The company has delivered a poor growth of 9.10% over past five years. Company has a low return on equity of 11.96% for last 3 years.

J B Chemicals Pharmaceuticals Ltd Price Chart

J B Chemicals Pharmaceuticals Ltd Price Chart

J B Chemicals Pharmaceuticals Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Sun Pharma.Inds. ₹169.4 28.81 ₹124,825.4 Cr. 0.77 -₹1,655.6 Cr. 24.82 -9.42 7585.25 10.53
2. Dr Reddy's Labs ₹5,046.75 36.47 ₹70,902.77 Cr. 0.59 ₹594.6 Cr. -12.11 14.73 4426.50 11.11
3. Cipla ₹767.1 34.95 ₹57,535.92 Cr. 0.42 ₹577.91 Cr. 20.85 8.95 4346.16 11.77
4. Aurobindo Pharma ₹806.2 15.87 ₹47,396.57 Cr. 0.37 ₹780.58 Cr. 20.99 8.82 5924.78 18.73
5. Biocon ₹439.6 70.21 ₹45,138 Cr. 0.13 ₹149.4 Cr. -27.58 14.56 1671.30 13.11
6. Torrent Pharma. ₹50.45 39.86 ₹45,039.6 Cr. 0.64 ₹321 Cr. 48.61 1.68 2056.00 15.01
7. Cadila Health. ₹426.35 26.88 ₹38,006.44 Cr. 0.94 ₹454 Cr. 49.54 4.11 3639.90 11.83
8. J B Chem & Pharm 23.30 ₹5,952.65 Cr. 1.43 ₹50.87 Cr. 38.62 9.95 416.87 21.81

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

J B Chemicals Pharmaceuticals Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020
Sales -284347305318366404352379411428385417
YOY Sales Growth %-9.69%15.20%10.22%3.99%28.91%16.38%15.49%19.05%12.27%5.92%9.38%9.95%
Expenses -253274246279292322280320319327301326
Material Cost %39.18%39.80%35.06%38.74%35.96%35.80%32.48%38.44%36.49%35.73%33.41%33.03%
Employee Cost %19.67%15.26%17.43%17.39%16.23%16.39%18.40%17.82%17.20%16.28%19.11%19.17%
Operating Profit3174593974827259921018491
OPM %11%21%19%12%20%20%21%16%22%24%22%22%
Other Income910511181615121816-7
Interest111111111110
Depreciation141414131414141116161717
Profit before tax2568493759757262881028367
Tax %19%24%31%40%29%31%36%33%33%6%25%24%
Net Profit205234224251464259966251
EPS in Rs2.326.114.032.635.036.165.645.137.3711.967.756.39
NotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotes

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Sales -7216688076868169571,0611,1441,1751,2501,5011,641
Sales Growth %32.17%-7.36%20.74%-14.91%18.94%17.16%10.96%7.75%2.71%6.38%20.13%9.30%
Expenses -6095316396207058218689189521,0501,2091,280
Material Cost %30.45%30.26%30.13%39.00%41.43%39.39%40.61%39.24%37.91%38.39%35.73%34.69%
Manufacturing Cost %4.42%5.04%5.48%7.76%8.50%9.47%9.60%11.12%11.21%10.74%9.71%8.45%
Employee Cost %12.96%14.75%14.44%14.78%14.73%13.79%13.86%14.57%16.03%17.43%17.22%17.94%
Other Cost %36.64%29.37%29.10%28.80%21.68%23.14%17.76%15.34%15.94%17.51%17.88%16.96%
Operating Profit11213716866111136193226222199292360
OPM %16%21%21%10%14%14%18%20%19%16%19%22%
Other Income1516678926-9105646393747
Interest15111024567105353
Depreciation202123222427384046565565
Profit before tax9212114180910894159231217179269340
Tax %14%16%16%21%21%27%29%22%20%29%32%21%
Net Profit791011186438568114179173128182268
EPS in Rs9.1711.6413.6669.239.527.5710.5421.1320.3915.3222.6934.70
Dividend Payout %11%17%14%54%30%37%105%24%5%13%22%3%

Compounded Sales Growth

  • 10 Years:: 9.40%
  • 5 Years:: 9.10%
  • 3 Years:: 11.78%
  • TTM:: 9.30%

Compounded Profit Growth

  • 10 Years:: 9.60%
  • 5 Years:: 19.01%
  • 3 Years:: 22.37%
  • TTM:: 50.33%

Return on Equity

  • 10 Years:: 21.74%
  • 5 Years:: 21.90%
  • 3 Years:: 40.74%
  • 1 Year:: 101.14%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Share Capital -171717171717171717171615
Equity Capital16.8716.8716.9016.9416.9416.9516.9616.9616.9616.7116.0515.46
Reserves5155976969379921,0319991,2061,3711,4371,4691,430
Borrowings17113616970509310517549282632
Other Liabilities -93121125149214201327244248285283334
Trade Payables334644345252626979100111111
Advance from Customers42021101481314
Other liability items557381113161149265175165177159209
Total Liabilities7968701,0071,1731,2731,3421,4491,6411,6841,7671,7931,811
Fixed Assets -221218225241294282301369609570552583
Gross Block3403583874214975115726809649801,0121,105
Accumulated Depreciation119140162180203229271310355410460522
CWIP70439546551354171516
Investments4662123338434536598612544567589536
Other Assets -523590655555540477495525528613636675
Inventories5556829190111128133160176208232
Trade receivables374407385131195248248266265301300344
Cash Equivalents4171123211149119117152112
Loans n Advances586157113971069911412312910489
Other asset items-6-589101101-27-84-1
Total Assets7968701,0071,1731,2731,3421,4491,6411,6841,7671,7931,811

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Cash from Operating Activity -9810913785180-12143171178116193272
Profit from operations151142165813101108195221227194296355
Receivables-56-2822179-41-61-9-3813-5013-19
Inventory10-1-25-91-21-17-5-27-16-32-24
Payables41853341-1112441325-24-2
Other WC items0000000000148
Working capital changes-42-1222031-93-141-0-40-424
Direct taxes-11-21-30-165-22-27-38-51-49-38-61-87
Cash from Investing Activity --17-29-89-236-112-139-122-52-42-24-2824
Fixed assets purchased-15-12-34-80-46-57-71-189-155-35-48-72
Fixed assets sold000820003672
Investments purchased-3-21-458-1,718-602-392-256-310-183-420-425-383
Investments sold033981,503529307204427292423436474
Interest received112921111111
Dividends received0024221060011
Other investing items000000012101-1
Cash from Financing Activity --55-515-526-3112-23-97-165-59-156-305
Proceeds from shares001200100000
Proceeds from borrowings0048004510920406
Repayment of borrowings-35-29-14-102-17-0-0-0-1560-00
Interest paid fin-14-12-10-13-4-3-4-2-3-3-4-2
Dividends paid-5-10-20-412-10-30-30-188-6-10-21-141
Financial liabilities00000000000-8
Other financing items000000000-50-131-161
Net Cash Flow27295288-62-138-222-30329-10

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ratios

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
ROCE %16%18%19%8%9%13%14%17%12%9%17%22%
Debtor Days190222174708795858582887377
Inventory Turnover3.923.953.863.454.184.214.043.853.413.203.122.87

Announcements & News

Recent Announcements

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at Fincash.com.
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in J B Chemicals Pharmaceuticals Ltd & Get More Returns than Bank Deposit

Disclaimer:
All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.